Post‐diagnosis dietary factors, supplement use and colorectal cancer prognosis: a Global Cancer Update Programme (CUP Global) systematic literature review and …

DSM Chan, M Cariolou, G Markozannes… - … journal of cancer, 2024 - Wiley Online Library
The role of diet in colorectal cancer prognosis is not well understood and specific lifestyle
recommendations are lacking. We searched for randomised controlled trials (RCTs) and …

Current applications and future directions of circulating tumor cells in colorectal cancer recurrence

KY Tsai, PS Huang, PY Chu, TNA Nguyen, HY Hung… - Cancers, 2024 - mdpi.com
Simple Summary The ability to predict or detect colorectal cancer (CRC) recurrence early
after surgery enables physicians to apply appropriate treatment plans and different follow-up …

The Gut Microbiota Metabolite Urolithin B Prevents Colorectal Carcinogenesis by Remodeling Microbiota and PD‐L1/HLA‐B

L Wang, J Chen, Q Chen, H Song… - Oxidative medicine …, 2023 - Wiley Online Library
Colorectal cancer has risen to the third occurring cancer in the world. Fluorouracil (5‐Fu),
oxaliplatin, and cisplatin are the most effective chemotherapeutic agents for clinical …

Comparative study of organoids from patient-derived normal and tumor colon and rectal tissue

A Costales-Carrera, A Fernández-Barral… - Cancers, 2020 - mdpi.com
Colon and rectal tumors, often referred to as colorectal cancer, show different gene
expression patterns in studies that analyze whole tissue biopsies containing a mix of tumor …

Circulating tumour cells in gastrointestinal cancers: food for thought?

S Asawa, M Nüesch, A Gvozdenovic… - British Journal of Cancer, 2023 - nature.com
Gastrointestinal (GI) cancers account for 35% of cancer-related deaths, predominantly due
to their ability to spread and generate drug-tolerant metastases. Arising from different …

Function and mechanisms of microRNA‑20a in colorectal cancer

Z Xiao, S Chen, S Feng, Y Li, J Zou… - Experimental and …, 2020 - spandidos-publications.com
Colorectal cancer (CRC) is the third most common malignancy and the second leading
cause of cancer‑associated mortality worldwide. CRC currently has no specific biomarkers …

Colorectal cancer recurrence prediction using a tissue-free epigenomic minimal residual disease assay

Y Nakamura, Y Tsukada, N Matsuhashi… - Clinical Cancer …, 2024 - aacrjournals.org
Purpose: Posttreatment detection of ctDNA is strongly predictive of recurrence. Most
minimal/molecular residual disease assays require prior tissue testing to guide ctDNA …

[HTML][HTML] The prognostic significance of serum lactate dehydrogenase-to-albumin ratio in colorectal cancer

U Aday, A Böyük, H Akkoç - Annals of Surgical Treatment …, 2020 - synapse.koreamed.org
Purpose The purpose of our study was initially to explore the prognostic role of LDH-to-
albumin ratio in patients with colorectal carcinoma (CRC) undergoing curative resection …

[HTML][HTML] LncRNA SLCO4A1-AS1 predicts poor prognosis and promotes proliferation and metastasis via the EGFR/MAPK pathway in colorectal cancer

R Tang, J Chen, M Tang, Z Liao, L Zhou… - … journal of biological …, 2019 - ncbi.nlm.nih.gov
It is universally acknowledged that long non-coding RNAs (lncRNAs) involved in
tumorigenesis in human cancers. However, the function and mechanism of many lncRNAs …

Finding Waldo: The Evolving Paradigm of Circulating Tumor DNA (CtDNA)—Guided Minimal Residual Disease (MRD) Assessment in Colorectal Cancer (CRC)

S Chakrabarti, AK Kasi, AR Parikh, A Mahipal - Cancers, 2022 - mdpi.com
Simple Summary After the surgical removal of colorectal cancer (CRC), residual cancer cells
undetectable by standard blood tests and imaging studies are responsible for cancer …